SAN FRANCISCO, Dec. 18, 2017 -- Zephyr Health, the leading Insights-as-a-Service solution provider for Life Sciences companies, today announced that Zephyr Illuminate™ has been selected as one of the Top Innovative Products of 2017 by PM360. As featured in PM360’s annual Innovation issue, Relationship Analytics, a new ground-breaking capability of Zephyr Illuminate, was recognized for its ability to help Biopharma companies unlock the value of customer relationship networks to improve commercial efforts.
Relationship Analytics is designed to put a physician’s network into medical and market context based on type, importance, and strength of relevant connections. The insights generated by Relationship Analytics bridge the gap between disparate data and actionable next steps for more effective stakeholder engagement and decision-making.
“We are honored by PM360’s industry recognition of Relationship Analytics,” said William King, Founder and Executive Chairman, Zephyr Health. “This award caps off a successful year for Zephyr Health, in which we broadened the capabilities of Zephyr Illuminate, expanded the mobile platform to iPhone, and welcomed new Top 50 Biopharma and Medical Device customers. We look forward to continuing this momentum in 2018 and bringing innovative products to Life Sciences companies that deliver a sustainable competitive edge.”
About Zephyr Health
Zephyr Health helps Life Sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading Insights-as-a-Service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, Life Sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Media Contact:
[email protected]


Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



